I have a personal opinion that the company is being hauled upon badly by the analysts, fund managers and others with their IN-VALUABLE recos. One should congratulate the company for coming out with the drug. Regarding Q4 financials, Q3 was good and after that there were good developments. Despite the results, the virus is spreading and it seems to be spreading fast. Also, the product can be exported to other countries. It seems the ANALYSTS have not intentionally cited this.
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.